These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of a new rapid diagnostic test kit to diagnose Sri Lankan cutaneous leishmaniasis caused by Leishmania donovani. De Silva G, Somaratne V, Senaratne S, Vipuladasa M, Wickremasinghe R, Wickremasinghe R, Ranasinghe S. PLoS One; 2017; 12(11):e0187024. PubMed ID: 29135995 [Abstract] [Full Text] [Related]
10. First Evidence from Sri Lanka for Subphenotypic Diversity within L. donovani-Induced Classical Cutaneous Leishmaniasis. Siriwardana Y, Deepachandi B, Weerasinghe S, Karunaweera N, Udagedara C, Warnasuriya W, Ranawaka RR, Kahawita I. Biomed Res Int; 2021 Feb; 2021():3537968. PubMed ID: 33575327 [Abstract] [Full Text] [Related]
13. Clinical manifestations of cutaneous leishmaniasis in Sri Lanka - possible evidence for genetic susceptibility among the Sinhalese. Samaranayake TN, Dissanayake VH, Fernando SD. Ann Trop Med Parasitol; 2008 Jul; 102(5):383-90. PubMed ID: 18577329 [Abstract] [Full Text] [Related]
15. Is leishmaniasis in Sri Lanka benign and be ignored? Karunaweera ND, Rajapaksa US. J Vector Borne Dis; 2009 Mar; 46(1):13-7. PubMed ID: 19326703 [Abstract] [Full Text] [Related]
16. A Comprehensive Review of Cutaneous Leishmaniasis in Sri Lanka and Identification of Existing Knowledge Gaps. Amarasinghe A, Wickramasinghe S. Acta Parasitol; 2020 Jun; 65(2):300-309. PubMed ID: 32052240 [Abstract] [Full Text] [Related]
17. The use of recombinant K39, KMP11, and crude antigen-based indirect ELISA as a serological diagnostic tool and a measure of exposure for cutaneous leishmaniasis in Sri Lanka. Karunathilake C, Alles N, Dewasurendra R, Weerasinghe I, Chandrasiri N, Piyasiri SB, Samaranayake N, Silva H, Manamperi N, Karunaweera N. Parasitol Res; 2023 Dec 29; 123(1):77. PubMed ID: 38157062 [Abstract] [Full Text] [Related]
18. Polymerase chain reaction detection of Leishmania DNA in skin biopsy samples in Sri Lanka where the causative agent of cutaneous leishmaniasis is Leishmania donovani. Ranasinghe S, Wickremasinghe R, Hulangamuwa S, Sirimanna G, Opathella N, Maingon RD, Chandrasekharan V. Mem Inst Oswaldo Cruz; 2015 Dec 29; 110(8):1017-23. PubMed ID: 26676321 [Abstract] [Full Text] [Related]
20. Evidence for Seroprevalence in Human Localized Cutaneous Leishmaniasis Caused by Leishmania donovani in Sri Lanka. Siriwardana YD, Deepachandi B, Ranasinghe S, Soysa P, Karunaweera N. Biomed Res Int; 2018 Dec 29; 2018():9320367. PubMed ID: 29581989 [Abstract] [Full Text] [Related] Page: [Next] [New Search]